PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
14-Feb-2023 In North America, Insulin Pump Market is expected to grow at an 8.7% CAGR through 2032 | FMI MARKITWIRED
14-Feb-2023 Opdivo® (nivolumab) in Combination with CABOMETYX® (cabozantinib) Shows Durable Survival with Over Three Years of Follow-Up in the CheckMate -9ER Trial in First-Line Advanced Renal Cell Carcinoma Businesswire
14-Feb-2023 Aptar Again Receives Platinum Rating from EcoVadis Businesswire
14-Feb-2023 Seagen to Highlight Research in Urothelial Cancer at the 2023 American Society of Clinical Oncology Genitourinary Cancers Symposium Businesswire
14-Feb-2023 Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2022 Results Businesswire
14-Feb-2023 Johnson & Johnson Appoints Dr. John Reed as Executive Vice President, Pharmaceuticals, R&D Businesswire
14-Feb-2023 Revelation Biosciences Inc. Announces Closing of $15.6 Million Public Offering Businesswire
13-Feb-2023 Grin Teledental Platform Now Available in Brazil Businesswire
13-Feb-2023 BioDuro-Sundia Expands Drug Discovery Capacity and Capability Businesswire
13-Feb-2023 Molecular Imaging Market is expected to value at US$ 7.3 Billion by 2032 MARKITWIRED
13-Feb-2023 Herbal Medicinal Products Market is expected to reach US$ 360.35 Billion by 2031 MARKITWIRED
13-Feb-2023 Farm Animal Drugs Market is expected to reach US$ 29.4 Billion by 2032 MARKITWIRED
13-Feb-2023 Obesity Management Market is predicted to grow at 5.1% CAGR through 2032 MARKITWIRED
13-Feb-2023 Auto Injectors Market is expected to reach US$ 23.9 Billion by 2032 MARKITWIRED
13-Feb-2023 Portable Oxygen Concentrators Market is likely to rise at 10.1% CAGR through 2032 MARKITWIRED
13-Feb-2023 Central Venous Catheter Market is expected to reach US$ 5.1 Billion by 2032 MARKITWIRED
13-Feb-2023 Intraosseous Infusion Devices Market is predicted to grow at 6.9% CAGR from 2023 to 2033 MARKITWIRED
13-Feb-2023 Traditional Wound Management Market is expected to reach US$ 6.9 Billion by 2032 MARKITWIRED
13-Feb-2023 ADDING MULTIMEDIA: MAIA Biotechnology’s Telomere-targeting Agent THIO, in Combination With Checkpoint Inhibitor Immune Therapies Atezolizumab (anti-PD-L1) or Pembrolizumab (anti-PD-1), Demonstrated Significantly Greater Tumor Inhibition Businesswire
13-Feb-2023 Baron & Budd Shareholder Roland Tellis Named Co-Lead Counsel in Class Action Lawsuit Involving Kia and Hyundai Defect Businesswire